Roche invests r $ 300 million in the plant in Rio de Janeiro

In five years, Roche will invest 300 million dollars in the factory of Jacarepaguá in Rio de Janeiro, to make the unit is the company for exporting pole Latin America.
The announcement was made today by means of communication, by the President of the Board of Directors of the Roche Group, Christoph Franz.
"The investment reinforces our commitment to Latin America and are fully aligned to our growth strategy in Brazil and the region," he said.
Clinical studies the company informs you that the site of Rio de Janeiro exports about 30% of total production for 23 countries – which corresponds to 16 million units of medicines.
The plan is that in two years, some of the medicines made in the country also will be exported.
Last year, Roche has invested worldwide over 9 billion Swiss francs in research and development, equivalent to 20% of revenues.
In Brazil, the company has 240 research centers participating in clinical studies 79.